|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Suite 1100,South San Francisco,California,US
|
|
Amunix is an immuno-oncology company leveraging our proprietary, clinically validated Pro-XTEN technology platform to discover and develop transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer. We aim to expand the therapeutic index of TCEs and cytokines, which have demonstrated anti-tumor clinical activity, but have not realized their potential due to dose-limiting on-target, off-tumor toxicity.
We address this challenge by using our universal, protease-releasable masking technology (Pro-XTEN), to create next generation, conditionally active TCEs (XPATs®) and cytokines (XPACs), that are preferentially activated in tumors as compared to healthy tissues.
Experience and culture matter. At Amunix, we challenge ourselves and our colleagues, and bring a critical eye and rigor to everything we do. Biology is complex and hard to predict, but with deep experience, diversity of thinking, and scientific rigor, we believe we maximize our chance of making a real difference for cancer patients.
|
Amunix Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
80%
|
The widely used Amunix Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 80% adoption across the company.
To contact Amunix Pharmaceuticals customer service number in your country click here to find.
Angie You is the CEO of Amunix Pharmaceuticals. To contact Angie You email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.